Helen Boucher
Overview
Explore the profile of Helen Boucher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Evans S, Follmann D, Liu Y, Holland T, Doernberg S, Rouphael N, et al.
Clin Infect Dis
. 2018 Oct;
68(11):1961-1967.
PMID: 30351426
Patient management is not based on a single decision. Rather, it is dynamic: based on a sequence of decisions, with therapeutic adjustments made over time. Adjustments are personalized: tailored to...
2.
Luepke K, Suda K, Boucher H, Russo R, Bonney M, Hunt T, et al.
Pharmacotherapy
. 2016 Nov;
37(1):71-84.
PMID: 27859453
Growing antimicrobial resistance and a dwindling antibiotic pipeline have resulted in an emerging postantibiotic era, as patients are now dying from bacterial infections that were once treatable. The fast-paced "Golden...
3.
Joseph A, Pilichowska M, Boucher H, Kiernan M, DeNofrio D, Inker L
Am J Kidney Dis
. 2015 Mar;
65(6):949-55.
PMID: 25773482
Polyomavirus-associated nephropathy (PVAN) has become an important cause of kidney failure in kidney transplant recipients. PVAN is reported to affect 1% to 7% of kidney transplant recipients, leading to premature...
4.
Rosenthal M, Mediavilla J, Chen L, Sonnenfeld J, Pierce L, Shannon A, et al.
Int J Infect Dis
. 2014 Dec;
29:146-51.
PMID: 25449249
Background: Knowledge of nasal carriage is important in predicting staphylococcal infection, and no information exists regarding the endemicity of Staphylococcus aureus in Haiti. Methods: We performed a cross-sectional analysis of...
5.
Thibodeau E, Boucher H, DeNofrio D, Pham D, Snydman D
Diagn Microbiol Infect Dis
. 2012 Jul;
74(1):68-9.
PMID: 22749241
Staphylococcus schleiferi subspecies coagulans is often misclassified as S. aureus given the production of a pseudocoagulase turning the tube coagulase test positive. It is therefore infrequently reported in the literature....
6.
Talbot G, Powers J, Fleming T, Siuciak J, Bradley J, Boucher H
Clin Infect Dis
. 2012 Jun;
55(8):1114-21.
PMID: 22744885
Efficacy endpoints for previous registrational trials of antimicrobials for acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP) were based on nonstandardized, clinician-based observations and decisions,...
7.
Spellberg B, Boucher H, Bradley J, Das A, Talbot G
Ann Emerg Med
. 2011 Jan;
57(2):183-5.
PMID: 21251530
No abstract available.
8.
Boucher H, Miller L, Razonable R
Clin Infect Dis
. 2010 Aug;
51 Suppl 2:S183-97.
PMID: 20731576
Although first identified just >4 decades ago, methicillin-resistant Staphylococcus aureus (MRSA) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide....
9.
Kanafani Z, Boucher H, Fowler V, Cabell C, Hoen B, Miro J, et al.
Enferm Infecc Microbiol Clin
. 2010 Mar;
28(8):498-503.
PMID: 20188444
Introduction: In a recent randomized trial of Staphylococcus aureus bacteremia and native valve endocarditis, daptomycin was found not inferior to standard therapy. We summarized findings in the subgroup of patients...
10.
Rifampin-containing regimens for community-associated skin infection: a hazard without known benefit
Miller L, Boucher H
Am J Emerg Med
. 2009 Aug;
27(7):893-4.
PMID: 19683124
No abstract available.